Oligodendrocyte Biology and Myelin Dynamics in the Central Nervous System

Oligodendrocytes are specialised glial cells responsible for the formation and maintenance of myelin sheaths around axons in the central nervous system (CNS). Myelin, a multilamellar membrane rich in lipids and proteins, insulates nerve fibres and enables rapid saltatory conduction of action potentials. During development, oligodendrocyte precursor cells (OPCs) proliferate, migrate and differentiate to generate mature oligodendrocytes, a process regulated by intrinsic transcriptional programmes and extrinsic cues from neurons and neighbouring glia. Myelin dynamics encompass both the initial ensheathment of axons and activity‐dependent remodelling in adulthood, contributing to plasticity, learning and circuit refinement. Demyelination, whether due to injury, inflammation or genetic mutation, disrupts conduction, compromises axonal integrity and can precipitate neurological deficits. Endogenous remyelination involves OPC recruitment, differentiation and new sheath formation, but this capacity declines with age and in chronic disease. Recent advances have elucidated molecular regulators of sheath assembly, lipid metabolism, cytoskeletal remodelling and neuron–glia signalling, revealing potential targets to promote repair and preserve neural function in demyelinating disorders.

Research from Nature Portfolio

Recent studies have demonstrated that activity‐regulated myelin plasticity within specific neural circuits is essential for adaptive behaviours. In dopaminergic pathways, oligodendrogenesis in the ventral tegmental area is modulated by neuronal firing and opioid exposure, with blockade of new oligodendrocyte formation impairing reward learning. This work highlights a novel role for myelin remodelling in neuromodulatory systems beyond classical motor tracts. In parallel, investigations into inflammatory demyelination have uncovered that OPCs can present antigen via major histocompatibility complex class I when exposed to pro-inflammatory cytokines. Such antigen presentation renders OPCs susceptible to cytotoxic T-cell attack, potentially perpetuating myelin loss in diseases like multiple sclerosis and identifying immune modulation of OPCs as a therapeutic avenue.

Oligodendrocyte Biology and Myelin Dynamics in the Central Nervous System publication trend

The graph below shows the total number of articles in oligodendrocyte biology and myelin dynamics in the central nervous system across all publications each year (not limited to Nature Index journals).

Technical terms

Oligodendrocyte: A glial cell type in the CNS that generates myelin sheaths around axons to facilitate rapid electrical conduction.

Myelin: A multilayered membrane produced by oligodendrocytes, composed of lipids and proteins, that insulates axons and accelerates nerve impulse transmission.

Oligodendrocyte Precursor Cell (OPC): A proliferative progenitor cell distributed throughout the CNS capable of differentiating into myelinating oligodendrocytes.

Demyelination: The loss or destruction of myelin sheaths, impairing nerve conduction and often triggering inflammation and axonal damage.

Remyelination: The biological process by which OPCs differentiate and form new myelin sheaths around demyelinated axons, restoring conduction and providing neuroprotection.

Myelin Plasticity: The dynamic modulation of myelin thickness, internode length or sheath number in response to neuronal activity, experience or injury.

Antigen Presentation: The display of peptide fragments on cell surface major histocompatibility complex molecules, enabling immune recognition by T cells.

References

1. Myelin plasticity in the ventral tegmental area is required for opioid reward. Nature (2024).
2. Oligodendrocyte precursor cells present antigen and are cytotoxic targets in inflammatory demyelination. Nature Communications (2019).
3. Palmitoylation regulates myelination by modulating the ZDHHC3-Cadm4 axis in the central nervous system. Signal Transduction and Targeted Therapy (2024).
4. Metformin Restores CNS Remyelination Capacity by Rejuvenating Aged Stem Cells. Cell Stem Cell (2019).